Mannkind (MNKD) Other Working Capital Changes (2010 - 2026)
Mannkind (MNKD) posted quarterly Other Working Capital Changes of -$4.9 million for Q1 2026, down 9.62% year-over-year from -$5.4 million in Q1 2025, and down 62.11% quarter-over-quarter from -$3.0 million in Q4 2025.
Mannkind (MNKD) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Other Working Capital Changes for 12 consecutive years, with -$4.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 9.62% year-over-year to -$4.9 million; the TTM figure through Mar 2026 stood at -$8.7 million (up 46.46% YoY), while the FY2025 annual figure was -$8.3 million, up 46.06% from the prior year.
- Other Working Capital Changes declined to -$4.9 million in Q1 2026 per MNKD's latest filing, from -$3.0 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $9.7 million in Q3 2023 and bottomed at -$11.4 million in Q4 2022.
- Historically, Other Working Capital Changes has averaged -$402687.5 across 5 years, with a median of $220500.0 in 2022.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes soared 9985.96% — and 2024, when it plunged 241.13%.
- Mannkind's Other Working Capital Changes stood at $5.6 million in 2022, then increased by 1.86% to $5.7 million in 2023, then slumped by 241.13% to -$8.1 million in 2024, then surged by 62.86% to -$3.0 million in 2025, then tumbled by 62.11% to -$4.9 million in 2026.
- Business Quant data shows MNKD's Other Working Capital Changes at -$4.9 million in Q1 2026, -$3.0 million in Q4 2025, and $1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.53 Mn |
| Jun 30, 2026 | 4.53 Mn |
| Jun 30, 2026 | 4.53 Mn |
| Mar 31, 2026 | 2.42 Mn |
| Mar 31, 2026 | 2.42 Mn |
| Mar 31, 2026 | 2.42 Mn |
| Sep 30, 2025 | 46,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Jun 30, 2025 | -2.58 Mn |
| Jun 30, 2025 | -2.58 Mn |
| Jun 30, 2025 | -2.58 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | -5.11 Mn |
| Dec 31, 2024 | -5.11 Mn |
| Dec 31, 2024 | -5.11 Mn |
| Sep 30, 2024 | 612,000.00 |
| Sep 30, 2024 | 612,000.00 |